METOX, founded by Maypharm Co., Ltd., a South Korean company founded in 2015. It provides a highly purified form of Clostridium Botulinum Toxin Type A, which targets moderate to severe facial wrinkles and muscle conditions. By using advanced vacuum dehydration technology, METOX minimizes powder residue. Each vial contains 100 units of active toxin, with human serum albumin and sodium chloride as excipients. Before use, the lyophilized powder requires reconstitution with a sterile, preservative-free 0.9% sodium chloride solution.